Colon carcinogenesis: Learning from NF-kappaB and AP-1.

Colorectal cancer (CRC) is among the most common types of cancer attributed to genetic alterations. Its manifestation implicates NF-kappaB and AP-1 signaling pathways by virtue of their regulative role on the genetic control of cell cycle and apoptosis as well as by their capacity to be constitutively activated or exogenously induced by growth factors, cytokines, stress signals and oncoproteins. In CRC, the positive impact of NF-kappaB and AP-1 on the transcription of angiogenic and invasive factors strongly implicates these transcription factors in the transition of benign carcinomas towards a metastatic phenotype. Furthermore, the deregulated function of NF-kappaB and AP-1 in CRC cells affects inflammatory cascades, manifested by the ample production of inflammatory mediators. In this perspective, inhibition of NF-kappaB and AP-1 signaling mechanisms has become a rational target in the development of novel therapeutic approaches against CRC.

[1]  A. Colell,et al.  Divergent role of ceramide generated by exogenous sphingomyelinases on NF‐κB activation and apoptosis in human colon HT‐29 cells , 2002, FEBS letters.

[2]  H. Buhr,et al.  Association between activation of atypical NF‐κB1 p105 signaling pathway and nuclear β‐catenin accumulation in colorectal carcinoma , 2009, Molecular carcinogenesis.

[3]  M. Karamouzis,et al.  PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas , 2006, Journal of Cancer Research and Clinical Oncology.

[4]  T. Curran,et al.  Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. , 1994, Molecular and cellular biology.

[5]  J. Budczies,et al.  Invasion associated up‐regulation of nuclear factor κB target genes in colorectal cancer , 2009, Cancer.

[6]  M. Bertagnolli,et al.  Molecular origins of cancer: Molecular basis of colorectal cancer. , 2009, The New England journal of medicine.

[7]  F. Campbell,et al.  Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. , 2004, Carcinogenesis.

[8]  M. Karamouzis,et al.  EGF-R is Expressed and AP-1 and NF-κ:B Are Activated in Stromal Myofibroblasts Surrounding Colon Adenocarcinomas Paralleling Expression of COX-2 and VEGF , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[9]  Han-Ming Shen,et al.  NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy , 2009, Apoptosis.

[10]  O. De Wever,et al.  Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[11]  J. Yamamoto-Furusho,et al.  Role of cytokines in inflammatory bowel disease. , 2008, World journal of gastroenterology.

[12]  A. Baldwin,et al.  Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression , 2006, Oncogene.

[13]  E. Wagner,et al.  The role of the transcription factor AP-1 in colitis-associated and β-catenin-dependent intestinal tumorigenesis in mice , 2008, Oncogene.

[14]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[15]  V. Castranova,et al.  Nuclear Factor-κB, an Unappreciated Tumor Suppressor: Figure 1. , 2007 .

[16]  A. Papavassiliou,et al.  NF-κB/PPARγ and/or AP-1/PPARγ ‘on/off’ switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression , 2006, International Journal of Colorectal Disease.

[17]  H. Iwao,et al.  AP-1 and colorectal cancer , 2006, InflammoPharmacology.

[18]  M. Karin,et al.  AP-1 in cell proliferation and survival , 2001, Oncogene.

[19]  Masao Omata,et al.  Inflammation and cancer: Role of nuclear factor‐kappaB activation , 2008, Cancer science.

[20]  C. Pham,et al.  The NF-kappaB-mediated control of ROS and JNK signaling. , 2006, Histology and histopathology.

[21]  F. Sinicrope,et al.  Role of cyclooxygenase-2 in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[22]  M. Karamouzis,et al.  The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis , 2007, Molecular Cancer Research.

[23]  M. Mareel,et al.  The role of bile acids in carcinogenesis. , 2001, Mutation research.

[24]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[25]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[26]  Ximing Xu,et al.  Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. , 2004, World journal of gastroenterology.

[27]  G. Sethi,et al.  Potential pharmacological control of the NF-κB pathway. , 2009, Trends in pharmacological sciences.

[28]  M. Fresno,et al.  Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1. , 2006, The Biochemical journal.